Literature DB >> 21062213

Manganese superoxide dismutase dimorphism relationship with severity and prognosis in cardiogenic shock due to dilated cardiomyopathy.

J C Charniot1, A Sutton, D Bonnefont-Rousselot, C Cosson, R Khani-Bittar, P Giral, N Charnaux, J P Albertini.   

Abstract

The aim was to determine (a) Ala-16Val-SOD2 dimorphisms; (b) allelic frequency and phenotype of a common Pro-Leu polymorphism in GPx1, in a cohort of patients with a cardiogenic shock (CS) due to dilated cardiomyopathy without acute coronary syndrome. Consecutive patients with de novo CS that worsened a dilated (DCM) or ischemic (ICM) cardiomyopathy. Congenital heart disease, pacemaker and other shock aetiologies were excluded. To determine oxidative stress (OS), this study evaluated lipid peroxidation, protein oxidation and erythrocyte GPx, SOD and catalase activities. Ala16Val-SOD2 (dbSNP: rs4880) and Pro198Leu-GPx1 (dbSNP: rs1050450) polymorphisms were studied by allelic discrimination using fluorogenic probes and the 5'nuclease (TaqMan) assay. Twenty-four patients (with ICM (n = 8) or DCM (n = 16), age = 57.5 ± 10.7 years, LVEF = 25.3 ± 8.5%, NT-proBNP levels = 8540 ± 1703 ng/L) were included during a 15 month follow-up. OS parameters were significantly higher in patients than in controls. Distribution of MnSOD genotypes was 47% Val/Val-variant, 29.5% Ala/Val and 23.5% Ala/Ala-variants. Severity of CS was more important in patients with Val/Val-variant and can be put in parallel with NT-proBNP levels (Val/Val-variant: 11 310 ± 3875 ng/L vs Ala/Ala-variant: 6486 ± 1375 ng/L and Ala/Val-variant: 6004 ± 2228 ng/L; p < 0.05) and hemodynamic support duration (144.6 vs Ala/Val-variant: 108.8 h and Ala/Ala-variant: 52.5 h; p < 0.05) with a positive correlation (Spearman rho = 0.72, p < 0.05). Moreover, Val/Val-variant significantly influenced the mortality (Spearman rho = 0.67, p < 0.05), but not the morbidity (p = 0.3). Distribution of GPx genotypes was 64% Pro/Pro, 18% Pro/Leu and 18% Leu/Leu. GPx-variants influenced neither GPx activities nor cardiac events. In conclusion, CS was associated with markers of increased OS. GPx polymorphism did not influence the GPx activity. Only the Val-encoding MnSOD allele was significantly correlated with the severity and prognosis of CS.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21062213     DOI: 10.3109/10715762.2010.532792

Source DB:  PubMed          Journal:  Free Radic Res        ISSN: 1029-2470


  9 in total

1.  Effects of Brazil nut consumption on selenium status and cognitive performance in older adults with mild cognitive impairment: a randomized controlled pilot trial.

Authors:  Bárbara Rita Cardoso; Daniel Apolinário; Verônica da Silva Bandeira; Alexandre Leopold Busse; Regina Miksian Magaldi; Wilson Jacob-Filho; Silvia Maria Franciscato Cozzolino
Journal:  Eur J Nutr       Date:  2015-01-08       Impact factor: 5.614

2.  Gene expression profiling of peripheral blood mononuclear cells in the setting of peripheral arterial disease.

Authors:  Rizwan Masud; Khader Shameer; Aparna Dhar; Keyue Ding; Iftikhar J Kullo
Journal:  J Clin Bioinforma       Date:  2012-03-12

Review 3.  Redox signalling and mitochondrial stress responses; lessons from inborn errors of metabolism.

Authors:  Rikke K J Olsen; Nanna Cornelius; Niels Gregersen
Journal:  J Inherit Metab Dis       Date:  2015-05-30       Impact factor: 4.982

4.  Superoxide dismutase activity as a predictor of adverse outcomes in patients with nonischemic dilated cardiomyopathy.

Authors:  Ewa Romuk; Wojciech Jacheć; Ewa Kozielska-Nowalany; Ewa Birkner; Aleksandra Zemła-Woszek; Celina Wojciechowska
Journal:  Cell Stress Chaperones       Date:  2019-05-01       Impact factor: 3.667

5.  MnSOD and GPx1 polymorphism relationship with coronary heart disease risk and severity.

Authors:  Yosra Souiden; Hela Mallouli; Salah Meskhi; Yassine Chaabouni; Ahmed Rebai; Foued Chéour; Kacem Mahdouani
Journal:  Biol Res       Date:  2016-04-11       Impact factor: 5.612

6.  The Impact of Superoxide Dismutase-1 Genetic Variation on Cardiovascular and All-Cause Mortality in a Prospective Cohort Study: The Yamagata (Takahata) Study.

Authors:  Yoichiro Otaki; Tetsu Watanabe; Satoshi Nishiyama; Hiroki Takahashi; Takanori Arimoto; Tetsuro Shishido; Takuya Miyamoto; Tsuneo Konta; Yoko Shibata; Hidenori Sato; Ryo Kawasaki; Makoto Daimon; Yoshiyuki Ueno; Takeo Kato; Takamasa Kayama; Isao Kubota
Journal:  PLoS One       Date:  2016-10-18       Impact factor: 3.240

7.  Interplay between Superoxide Dismutase, Glutathione Peroxidase, and Peroxisome Proliferator Activated Receptor Gamma Polymorphisms on the Risk of End-Stage Renal Disease among Han Chinese Patients.

Authors:  Chia-Ter Chao; Yen-Ching Chen; Chih-Kang Chiang; Jenq-Wen Huang; Cheng-Chung Fang; Chen-Chih Chang; Chung-Jen Yen
Journal:  Oxid Med Cell Longev       Date:  2016-01-06       Impact factor: 6.543

8.  A targeted metabolomics assay for cardiac metabolism and demonstration using a mouse model of dilated cardiomyopathy.

Authors:  James A West; Abdelaziz Beqqali; Zsuzsanna Ament; Perry Elliott; Yigal M Pinto; Eloisa Arbustini; Julian L Griffin
Journal:  Metabolomics       Date:  2016-03-07       Impact factor: 4.290

9.  Integrated Left Ventricular Global Transcriptome and Proteome Profiling in Human End-Stage Dilated Cardiomyopathy.

Authors:  Dilek Colak; Ayodele A Alaiya; Namik Kaya; Nzioka P Muiya; Olfat AlHarazi; Zakia Shinwari; Editha Andres; Nduna Dzimiri
Journal:  PLoS One       Date:  2016-10-06       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.